Business Description





We are a leading provider of manufactured vinyl coated fabrics. Our best-known
brand, Naugahyde, is the product of many improvements on a rubber-coated fabric
developed a century ago in Naugatuck, Connecticut. We design, manufacture and
market a wide selection of vinyl coated fabric products under a portfolio of
recognized brand names. We believe that our business has continued to be a
leading supplier in its marketplace because of our ability to provide
specialized materials with performance characteristics customized to the
end-user specifications, complemented by technical and customer support for the
use of our products in manufacturing.



Our vinyl coated fabric products have undergone considerable evolution and today
are distinguished by superior performance in a wide variety of applications as
alternatives to leather, cloth and other synthetic fabric coverings. Our
standard product lines consist of more than 600 SKUs with combinations of
colors, textures, patterns and other properties. Our products are differentiated
by unique protective top finishes and transfer print capabilities. Additional
process capabilities include embossing grains and patterns, and rotogravure
printing, which imparts five color character prints and non-registered prints,
lamination and panel cutting.



Our vinyl coated fabric products have various high-performance characteristics
and capabilities. They are durable, stain resistant, easily processed, more
cost-effective and better performing than traditional leather or fabric
coverings. Our products are frequently used in applications that require
rigorous performance characteristics such as automotive and non-automotive
transportation, certain indoor/outdoor furniture, commercial and hospitality
seating, healthcare facilities and athletic equipment. We manufacture materials
in a wide range of colors and textures. They can be hand or machine sewn,
laminated to an underlying structure, thermoformed to cover various substrates
or made into a variety of shapes for diverse end-uses. We are a long-established
supplier to the global automotive industry and manufacture products for interior
soft trim components from floor to headliner, which are produced to meet
specific component production requirements such as cut and sew, vacuum
forming/covering, compression molding, and high frequency welding. Some products
are supplied with micro perforations, which are necessary on most compression
molding processes. Materials can also be combined with polyurethane or
polypropylene foam laminated by either flame or hot melt adhesive for seating,
fascia and door applications.



Products are developed and marketed based upon the performance characteristics
required by end-users. For example, for recreational products used outdoors,
such as boats, personal watercraft, golf carts and snowmobiles, a product
designed primarily for water-based durability and weatherability is used. We
also manufacture a line of products called BeautyGard®, with water-based
topcoats that contain agents to protect against bacterial and fungal
micro-organisms and can withstand repeated cleaning, a necessity in the
restaurant and health care industries. These topcoats are environmentally
friendlier than solvent-based topcoats. The line is widely used in hospitals and
other healthcare facilities. Flame and smoke retardant vinyl coated fabrics are
used for a variety of commercial and institutional furniture applications,
including hospitals, restaurants and residential care centers and seats for
school buses, trains and aircraft.



We currently conduct our operations in manufacturing facilities that are located in Stoughton, Wisconsin and Earby, England.

Critical Accounting Policies and Estimates





The preparation of our consolidated financial statements and related disclosures
in conformity with U.S. generally accepted accounting principles ("U.S. GAAP")
requires management to make estimates and judgments that affect our reported
amounts of assets and liabilities, revenues and expenses, and related
disclosures of contingent assets and liabilities. On an on-going basis, we
evaluate our estimates and assumptions based upon historical experience and
various other factors and circumstances. We believe that our estimates and
assumptions are reasonable under the circumstances; however, actual results may
vary from these estimates and assumptions under different future circumstances.
For further discussion of our significant accounting policies, refer to Note 1 -
"Summary of Significant Accounting Policies" to the consolidated financial
statements and "Management's Discussion and Analysis of Financial Condition and
Results of Operations - Critical Accounting Policies, Judgments and Estimates"
in our Annual Report on Form 10-K for the fiscal year ended December 29, 2019.



  21


   Table of Contents



Recent Accounting Pronouncements

See Note 14 - "Recent Accounting Standards" to the consolidated financial statements for a discussion of recent accounting guidance.





Overview:



The Company and its subsidiaries use a 52/53-week fiscal year ending on the
Sunday nearest to December 31. The current year ending January 3, 2021 is a
53-week year whereas the prior year ended December 29, 2019 was a 52-week year.
The Company's U.K. subsidiaries use the calendar year end of December 31. The
activity of the U.K. subsidiaries that occurs on the days that do not coincide
with the Company's year-end is not material. The three months ended October 4,
2020 and September 29, 2019 were both 13-week periods while the nine months
ended October 4, 2020 was a 40-week period and the nine months ended September
29, 2019 was a 39-week period.



Our Earby, England operation's functional currency is the British Pound Sterling
("Pound Sterling") and has sales and purchases transactions that are denominated
in currencies other than the Pound Sterling, principally the Euro. Approximately
26% of the Company's global revenues and 29% of its global raw material
purchases are derived from these Euro transactions.



The average year-to-date exchange rate for the Pound Sterling to the U.S. Dollar
was approximately 0.5% lower and the average exchange rate for the Euro to the
Pound Sterling was approximately 0.1% higher in 2020 compared to 2019. These
small exchange rate changes had the effect of slightly increasing net sales by
approximately $2,000 for the nine months ended October 4, 2020. The overall
currency effect on the Company's net loss was a positive amount of approximately
$4,000 for the nine months ended October 4, 2020.



On January 27, 2020, the Company announced a one-for-five reverse stock split
("reverse stock split") on its common stock that became effective on February
24, 2020. The amounts in common stock and additional paid-in capital were
adjusted as of the effective date to reflect the reverse stock split. Share and
per share amounts for the three and nine months ended September 29, 2019 have
been restated to give effect to the reverse stock split.



The U.K. exit from the European Union on January 31, 2020, commonly referred to
as Brexit, has caused, and may continue to cause, uncertainty in the global
markets. Political and regulatory responses to the withdrawal are still
developing, and we are in the process of assessing the impact that the
withdrawal may have on our business as more information becomes available. Any
impact from Brexit on our business and operations over the long term will
depend, in part, on the outcome of tariff, tax treaties, trade, regulatory, and
other negotiations the U.K. conducts.



Subsequent to year-end 2019, the World Health Organization declared the novel
coronavirus ("COVID-19") outbreak a public health emergency. There have been
mandates from international, federal, state and local authorities requiring
forced closures of various schools, businesses and other facilities and
organizations although there have been some recent easings of these closures.
These forced closures have negatively impacted the Company's business. Primarily
due to the negative impact that COVID-19 is having on the global economy, the
Company began to experience a decline in sales during the latter part of March
2020. In order to mitigate the effect of the decrease in revenue, the Company is
managing its costs, which included initially reducing staff at its manufacturing
facilities with production at one-third capacity at the U.S. facility and the
entire production staff furloughed at the U.K. facility beginning in late March.
During June 2020, the Company had some employees return to work as its U.K.
facility started limited production of vinyl products based on orders it was
receiving from its customers. The Company brought back additional production
workers as incoming orders increased during the third quarter of 2020. Demand
for our products continues to improve in the fourth quarter although it is

well
below normalized levels.



Additionally, the Company has applied for loans under programs offered by the
governmental agencies in the United States and in the United Kingdom and is
exploring options for other supplementary cash flow opportunities to provide
further liquidity.



  22


   Table of Contents




For the U.S. operations, during the second quarter of 2020 the Company received
$2,217,500 in funds from One Community Bank (formerly Oregon Community Bank)
through the Paycheck Protection Program ("PPP") administered by the U.S. Small
Business Administration ("SBA") under the Coronavirus Aid, Relief, and Economic
Security Act ("the CARES Act"). The loan matures on April 13, 2022 and bears an
interest rate of 1.0%. The Company is required to make monthly payments of
principal and interest beginning November 13, 2020 based on the amount that is
outstanding on October 13, 2020 in order to fully amortize the loan by April 13,
2022. The loan may be prepaid by the Company at any time prior to maturity

with
no prepayment penalties.



All or a portion of the loan may be forgiven by the SBA for costs the Company
incurs for payroll, rent, utilities and all other allowable expenses during the
24-week period beginning April 13, 2020. The Company used all proceeds from the
loan to maintain payroll and make payments for lease, utility and other
allowable expenses. Included in the accompanying consolidated statements of
operations for the nine months ended October 4, 2020 was $2,217,500 of loan
forgiveness that the Company expects to receive from the SBA. Although the
Company has not been legally released from this amount of the loan, management
concluded that there was reasonable assurance that the Company had substantially
met the terms for forgiveness and therefore recognized this amount as income as
a component of other income (expense). The Company submitted its application for
loan forgiveness to One Community Bank in September 2020.



Also for the U.S. operations, during the third quarter of 2020 the Company applied for a $3.2 million loan from Wells Fargo Capital Finance, LLC through the Main Street Lending Program established by the Federal Reserve Board; however, there can be no guarantee that the Company will be successful in obtaining this funding.


For the U.K. operations, during the three and nine months ended October 4, 2020
the Company recorded reimbursed costs of approximately $474,000 and $1,560,000,
respectively, under the Coronavirus Job Retention Scheme ("CJRS") set up by the
U.K. government to help employers pay the wages of those employees who would
otherwise have been laid off during the coronavirus outbreak but under the CJRS
were furloughed instead. This program reimbursed the Company for 80% of the
compensation expense plus national insurance and certain benefits paid to the
furloughed employees, resulting in lower salary expense for the Company. While
the employees were on furlough, the compensation paid to them was limited to the
amount reimbursed by the CJRS. The Company recorded the reimbursed amounts as
reductions to the associated expenses.



Additionally for the U.K. operations, during the third quarter of 2020 the Company received a $783,958 loan from its principal shareholder and $1,545,538 in loans from automotive lenders. These funds provided additional working capital to meet various short-term cash needs.





While the closures and limitations on movement, domestically and
internationally, are expected to be temporary due to the COVID-19 outbreak, the
duration of the supply chain disruption and related financial impact cannot be
estimated at this time. Should the closures continue for an extended period of
time or should the effects of the coronavirus continue to spread, the impact
could have a material adverse effect on the Company's financial position,
results of operations and cash flows which may require that the Company obtain
additional financing.



  23


   Table of Contents



Three Months Ended October 4, 2020 Compared to the Three Months Ended September 29, 2019

The following table sets forth, for the three months ended October 4, 2020 ("three months 2020") and September 29, 2019 ("three months 2019"), certain operational data including their respective percentage of net sales:





                                                               Three Months Ended
                                                                                                             %
                                   October 4, 2020             September 29, 2019           Change         Change

Net Sales                      $ 15,171,898       100.0 %   $ 22,033,539       100.0 %   $ (6,861,641 )     -31.1%
Cost of Goods Sold               13,114,967        86.4 %     18,471,639        83.8 %     (5,356,672 )     -29.0%
Gross Profit                      2,056,931        13.6 %      3,561,900        16.2 %     (1,504,969 )     -42.3%
Operating Expenses:
Selling                             778,699         5.1 %      1,061,781         4.8 %       (283,082 )     -26.7%
General and administrative        1,957,486        12.9 %      1,373,118         6.2 %        584,368        42.6%
Research and development            198,182         1.3 %        377,989         1.7 %       (179,807 )     -47.6%
Total Operating Expenses          2,934,367        19.3 %      2,812,888        12.8 %        121,479         4.3%
Operating (Loss) Income            (877,436 )      -5.8 %        749,012         3.4 %     (1,626,448 )     <-100%
Interest expense                   (367,454 )      -2.4 %       (509,829 )      -2.3 %        142,375       -27.9%
Funding from Paycheck
Protection Program                   33,824         0.2 %              -         0.0 %         33,824            -
Other income                         85,753         0.6 %         50,213         0.2 %         35,540        70.8%
(Loss) Income before Tax
Provision                        (1,125,313 )      -7.4 %        289,396         1.3 %     (1,414,709 )     <-100%
Tax (benefit) provision            (111,318 )      -0.7 %         12,022         0.1 %       (123,340 )     <-100%
Net (Loss) Income                (1,013,995 )      -6.7 %        277,374         1.3 %     (1,291,369 )     <-100%
Preferred stock dividend           (808,638 )      -5.3 %       (777,372 )      -3.5 %        (31,266 )       4.0%
Net Loss Allocable to Common
Shareholders                   $ (1,822,633 )     -12.0 %   $   (499,998 )      -2.3 %   $ (1,322,635 )      >100%






Revenue:


Total revenue for the three months 2020 decreased $6,861,641 or 31.1% to $15,171,898 from $22,033,539 for the three months 2019. There was a favorable currency effect of approximately $367,000 on total revenue.





For the three months 2020 compared to the three months 2019, U.S. automotive
sales decreased 47.7% and European automotive sales decreased 33.8% (excluding
the currency adjustment). This significant decrease was principally due to the
COVID-19 pandemic, where most of the Company's customers in this market and the
OEMs of the automobiles that use the Company's products, shut down production
lines or their entire production facilities at the end of the first quarter 2020
and continued into the second quarter 2020 as the pandemic continued. The
automotive market began to improve at the end of the second quarter as most of
the customers and OEMs were restarting their production facilities. Due to the
continuing improvement in the automotive market and the Company retaining all of
its programs, the Company's sales activity increased significantly in the third
quarter 2020 as compared to the second quarter 2020. However, it had not yet
reached the run-rate of the period prior to the onset of COVID-19.



  24


   Table of Contents




Additionally, sales for the industrial sector decreased 22.7% (23.2% before
currency effect) primarily due to a decline in the U.S. contract market. The
negative impact of COVID-19 on the global economy was a major factor in the
overall decline in sales. However, as with automobile sales, industrial sales
increased in the third quarter 2020 as compared to the second quarter 2020.



Also impacting 2020 revenue to a lesser degree, the Company in August 2019,
decommissioned and shut down equipment in the U.K. that manufactured calender
product for both the automotive and industrial market. The Company had built
sufficient inventory of this product to service its customers for several months
after the shutdown. Shortly before the shutdown, the Company entered into
agreements with another company to provide some of the calender film it
originally produced. Once the film was further processed by the Company, it was
able to continue offering certain products to one of its customers. During the
three months 2020, the Company sold $407,550 of calender product principally
using the purchased film compared to $1,159,209 for the three months 2019. Of
these amounts, all were in the automotive market for the three months 2020 and
$957,578 were in the automotive market for the three months 2019.



Gross Profit:



Total gross profit for the three months 2020 decreased $1,504,969 or 42.3% to
$2,056,931 from $3,561,900 for the three months 2019. The gross profit
percentage was 13.6% of sales for the three months 2020 compared to 16.2% for
the three months 2019. The lower amount and percentage for the three months 2020
were primarily due to the impact of COVID-19 including production inefficiencies
caused by smaller runs associated with less demand. Gross profit amount and
percentage were much higher as compared to the second quarter of 2020 primarily
due to the continuing improvement in sales. During the third quarter of 2020,
manufacturing costs were reduced approximately $370,000 due to reimbursements
through the CJRS for the salaries of furloughed employees. There was a favorable
currency effect of approximately $36,000 on gross profit.



Operating Expenses:



Selling expenses for the three months 2020 decreased $283,082 or 26.7% to
$778,699 from $1,061,781 for the three months 2019. Due to the lower sales
activity primarily as a result of COVID-19, selling expenses such as commission,
travel and entertainment were reduced in 2020. In addition, the Company was
reimbursed approximately $43,000 through the CJRS for the wages of furloughed
employees resulting in lower salary expense. Also contributing to the lower
selling expenses in 2020 was the 2019 closure of the calender product line and
the elimination of its applicable employment and commission costs. There was a
$16,000 unfavorable currency effect that partially offset the decrease in
selling expenses.



General and administrative expenses for the three months 2020 increased $584,368
or 42.6% to $1,957,486 from $1,373,118 for the three months 2019. The increase
was primarily due to costs for cash management consulting services provided to
the Company and a charge relating to a legal proceeding in the U.K., as
previously discussed. Partially offsetting the increase were approximately
$15,000 in wages that were reimbursed through the CJRS. Included in the increase
in general and administrative expenses was an unfavorable currency effect of
$46,000.



Research and development expenses for the three months 2020 decreased $179,807
or 47.6% to $198,182 from $377,989 for the three months 2019. The decrease was
principally a decline in activities attributable to the COVID-19 pandemic
including lower development costs for new trials and wages of approximately
$46,000 that were reimbursed through the CJRS. There was a $3,000 unfavorable
currency effect that partially offset the decrease in research and development
expenses.



  25


   Table of Contents




Operating Income (Loss):



Operating loss for the three months 2020 was $877,436 compared to operating
income of $749,012 for the three months 2019, a decrease of $1,626,448. The
decrease was primarily due to the decline in gross profit as a result of
COVID-19. The operating loss percentage was -5.8% of sales for the three months
2020 compared to the operating income percentage of 3.4% for the three months
2019.



Interest Expense:



Interest expense for the three months 2020 decreased $142,375 or 27.9% to
$367,454 from $509,829 for the three months 2019. The decrease was primarily due
to lower interest rates on LIBOR and prime during the three months 2020 compared
to the three months 2019.


Funding from Paycheck Protection Program:


For the three months 2020, the $33,824 funding from the PPP was the amount of
proceeds from the PPP loan that the Company used during the third quarter for
allowable expenses under the PPP. The Company expects to receive forgiveness on
this debt from the SBA under the CARES Act for these eligible costs incurred by
the Company, as previously discussed.



Other Income:



Other income for the three months 2020 was $85,753 compared to other income of
$50,213 for the three months 2019. Included in other income are the currency
gains and losses recognized on foreign currency transactions and the change in
the fair value of financial assets and liabilities that are denominated in Euros
as these currencies fluctuated during the period. Also included in other income
are gains and losses from the change in fair values on the Company's foreign
currency exchange contracts.



Tax Provision (Benefit):



The Company files income tax returns in the United States as a C-Corporation,
and in several state jurisdictions and in the United Kingdom. The Company's U.S.
operating subsidiary, Uniroyal, is a limited liability company (LLC) for federal
and state income tax purposes and as such, its income, losses, and credits are
allocated to its members. The Company made the acquisition of Uniroyal through
UEPH, a limited liability company, which issued preferred ownership interests to
the sellers that provide for quarterly dividends. Uniroyal's taxable income is
allocated entirely to UEPH as its sole member and since it is a pass-through
entity, this income less the dividends paid to the sellers of Uniroyal is
reported on the Company's tax return. The taxable income applicable to the
dividends for the preferred ownership interests is reported to the sellers who
report it on their respective individual tax returns.



The Company does not have a history of repatriating a significant portion of its
foreign cash. However, if it decided to repatriate these foreign amounts to fund
U.S. operations, the Company would not be required to pay any additional U.S.
tax related to these amounts since the Company previously recorded a one-time
transition tax on deemed repatriation of deferred foreign income.



The tax benefit for the three months 2020 was $111,318 compared to a tax
provision of $12,022 for the three months 2019. The tax benefit for the three
months 2020 was principally attributable to the results of the U.K. operations
and the tax provision for the three months 2019 was principally attributable to
the results of the U.S. operations.



Preferred Stock Dividend:



The terms of the acquisitions in November 2014 resulted in the issuance of
preferred ownership units/stock of UEP Holdings, LLC and UGEL (formerly EPAL) to
the sellers. These preferred units have carried quarterly dividend requirements
on a total value of $55,000,000 at rates ranging from 5.0% to 8.0%. The dividend
rate on the Series B UEP Holdings preferred units which started at 5.5%
increases by 0.5% on the anniversary of the issuance up to a maximum of 8.0%.
The payment of dividends for the first three quarters of 2020 and the three
months ended December 29, 2019 was deferred to preserve cash and provide
additional liquidity. As of October 4, 2020 and December 29, 2019, accrued
dividends of $3,154,042 and $788,599, respectively, were included in accrued
expenses and other liabilities in the accompanying consolidated balance sheets.



  26


   Table of Contents



Nine Months Ended October 4, 2020 Compared to the Nine Months Ended September 29, 2019





The following table sets forth, for the nine months ended October 4, 2020 ("nine
months 2020") and September 29, 2019 ("nine months 2019"), certain operational
data including their respective percentage of net sales:



                                                                 Nine Months Ended
                                                                                                               %
                                   October 4, 2020             September 29, 2019           Change          Change

Net Sales                      $ 43,528,393       100.0 %   $ 71,523,182       100.0 %   $ (27,994,789 )      -39.1%
Cost of Goods Sold               37,931,227        87.1 %     59,434,689        83.1 %     (21,503,462 )      -36.2%
Gross Profit                      5,597,166        12.9 %     12,088,493        16.9 %      (6,491,327 )      -53.7%
Operating Expenses:
Selling                           2,278,279         5.2 %      3,348,622         4.7 %      (1,070,343 )      -32.0%
General and administrative        4,834,011        11.1 %      4,332,978         6.1 %         501,033         11.6%
Research and development            704,239         1.6 %      1,302,707         1.8 %        (598,468 )      -45.9%
Other operating expenses                  -         0.0 %        343,003         0.5 %        (343,003 )     -100.0%
Total Operating Expenses          7,816,529        18.0 %      9,327,310        13.0 %      (1,510,781 )      -16.2%
Operating (Loss) Income          (2,219,363 )      -5.1 %      2,761,183         3.9 %      (4,980,546 )      <-100%
Interest expense                 (1,215,771 )      -2.8 %     (1,547,343 )      -2.2 %         331,572        -21.4%
Funding from Paycheck
Protection Program                2,217,500         5.1 %              -         0.0 %       2,217,500             -
Other (expense) income             (185,417 )      -0.4 %         53,396         0.1 %        (238,813 )      <-100%
(Loss) Income before Tax
Provision                        (1,403,051 )      -3.2 %      1,267,236         1.8 %      (2,670,287 )      <-100%
Tax benefit                        (404,141 )      -0.9 %         (6,287 )       0.0 %        (397,854 )       >100%
Net (Loss) Income                  (998,910 )      -2.3 %      1,273,523         1.8 %      (2,272,433 )      <-100%
Preferred stock dividend         (2,396,479 )      -5.5 %     (2,339,862 )      -3.3 %         (56,617 )        2.4%
Net Loss Allocable to Common
Shareholders                   $ (3,395,389 )      -7.8 %   $ (1,066,339 )      -1.5 %   $  (2,329,050 )       >100%




Revenue:


Total revenue for the nine months 2020 decreased $27,994,789 or 39.1% to $43,528,393 from $71,523,182 for the nine months 2019. There was a favorable currency effect of approximately $2,000 on total revenue.


For the nine months 2020 compared to the nine months 2019, U.S. automotive sales
decreased 49.2% and European automotive sales decreased 45.2% (excluding the
currency adjustment). This significant decrease was principally due to the
COVID-19 pandemic, where most of the Company's customers in this market and the
OEMs of the automobiles that use the Company's products, shut down production
lines or their entire production facilities at the end of the first quarter 2020
and continued into the second quarter 2020 as the pandemic continued. The
automotive market began to improve at the end of the second quarter as most of
the customers and OEMs were restarting their production facilities. Due to the
continuing improvement in the automotive market and the Company retaining all of
its programs, the Company's sales activity increased significantly in the third
quarter 2020 as compared to the second quarter 2020. However, it had not yet
reached the run-rate of the period prior to the onset of COVID-19.



Additionally, sales for the industrial sector decreased 25.6% (the same as
before the currency effect) primarily due to a decline in the U.S. contract
market. The negative impact of COVID-19 on the global economy was a major factor
in the overall decline in sales which principally began during the latter part
of March 2020.



  27


   Table of Contents




Also impacting 2020 revenue to a lesser degree, the Company in August 2019,
decommissioned and shut down equipment in the U.K. that manufactured calender
product for both the automotive and industrial market. The Company had built
sufficient inventory of this product to service its customers for several months
after the shutdown. Shortly before the shutdown, the Company entered into
agreements with another company to provide some of the calender film it
originally produced. Once the film was further processed by the Company, it was
able to continue offering certain products to one of its customers. During the
nine months 2020, the Company sold $1,153,432 of calender product principally
using the purchased film compared to $3,980,459 for the nine months 2019. Of
these amounts, $1,098,901 and $2,944,107 were in the automotive market for the
nine months 2020 and 2019, respectively.



Gross Profit:



Total gross profit for the nine months 2020 decreased $6,491,327 or 53.7% to
$5,597,166 from $12,088,493 for the nine months 2019. The gross profit
percentage was 12.9% of sales for the nine months 2020 compared to 16.9% for the
nine months 2019. Gross profit amount and percentage were negatively impacted by
the effect of COVID-19 including production inefficiencies caused by smaller
runs associated with less demand. During the nine months 2020, manufacturing
costs were reduced approximately $1,304,000 due to reimbursements through the
CJRS for the salaries of furloughed employees. There was a favorable currency
effect of approximately $4,000 on gross profit.



Operating Expenses:



Selling expenses for the nine months 2020 decreased $1,070,343 or 32.0% to
$2,278,279 from $3,348,622 for the nine months 2019. Due to lower sales activity
primarily as a result of COVID-19, selling expenses such as commission, travel
and entertainment were reduced in 2020. In addition, the Company was reimbursed
approximately $99,000 through the CJRS for the wages of furloughed employees
resulting in lower salary expense. Also contributing to the lower selling
expenses in 2020 was the 2019 closure of the calender product line and the
elimination of its applicable employment and commission costs. There was a
favorable currency effect that slightly contributed to the decrease in selling
expenses also.



General and administrative expenses for the nine months 2020 increased $501,033
or 11.6% to $4,834,011 from $4,332,978 for the nine months 2019. This increase
was primarily due to costs for cash management consulting services provided to
the Company and a charge relating to a legal proceeding in the U.K., as
previously discussed. Partially offsetting the increase were wages of
approximately $35,000 that were reimbursed through the CJRS. There was a
favorable currency effect that slightly offset the increase in general and
administrative expenses.



Research and development expenses for the nine months 2020 decreased $598,468 or
45.9% to $704,239 from $1,302,707 for the nine months 2019. The decrease was
principally decreased activities attributable to the COVID-19 pandemic including
lower development costs for new trials and wages of approximately $122,000 that
were reimbursed through the CJRS. There was a favorable currency effect that
slightly contributed to the decrease in selling expenses also.



There were no other operating expenses for the nine months 2020 and $343,003 for 2019. The amount for 2019 was cost incurred by the Company as part of a restructuring plan to reduce inefficiencies at its U.K. facility.





Operating Income (Loss):



Operating loss for the nine months 2020 was $2,219,363 compared to operating
income of $2,761,183 for the nine months 2019, a decrease of $4,980,546. The
decrease was due to the decline in gross profit partially offset by the decrease
in operating expenses, which included the $343,003 non-recurring restructuring
charge in 2019. The operating loss percentage was -5.1% of sales for the nine
months 2020 compared to the operating income percentage of 3.9% for the nine
months 2019.



Interest Expense:


Interest expense for the nine months 2020 decreased $331,572 or 21.4% to $1,215,771 from $1,547,343 for the nine months 2019. The decrease was primarily due to lower interest rates on LIBOR and prime during the nine months 2020 compared to the nine months 2019.

Funding from Paycheck Protection Program:

For the nine months 2020, the $2,217,500 funding from the PPP is the amount of debt forgiveness that the Company expects to receive from the SBA under the CARES Act for eligible costs incurred by the Company, as previously discussed.





  28


   Table of Contents




Other Income (Expense):



Other expense for the nine months 2020 was $185,417 compared to other income of
$53,396 for the nine months 2019. Included in other income (expense) are the
currency gains and losses recognized on foreign currency transactions and the
change in the fair value of financial assets and liabilities that are
denominated in Euros as these currencies fluctuated during the period. Also
included in other income (expense) are gains and losses from the change in fair
values on the Company's foreign currency exchange contracts.



Tax Benefit:



The Company files income tax returns in the United States as a C-Corporation,
and in several state jurisdictions and in the United Kingdom. The Company's U.S.
operating subsidiary, Uniroyal, is a limited liability company (LLC) for federal
and state income tax purposes and as such, its income, losses, and credits are
allocated to its members. The Company made the acquisition of Uniroyal through
UEPH, a limited liability company, which issued preferred ownership interests to
the sellers that provide for quarterly dividends. Uniroyal's taxable income is
allocated entirely to UEPH as its sole member and since it is a pass-through
entity, this income less the dividends paid to the sellers of Uniroyal is
reported on the Company's tax return. The taxable income applicable to the
dividends for the preferred ownership interests is reported to the sellers who
report it on their respective individual tax returns.



The Company does not have a history of repatriating a significant portion of its
foreign cash. However, if it decided to repatriate these foreign amounts to fund
U.S. operations, the Company would not be required to pay any additional U.S.
tax related to these amounts since the Company previously recorded a one-time
transition tax on deemed repatriation of deferred foreign income.



The tax benefit for the nine months 2020 was $404,141, principally attributable
to the results of the U.S. operations, compared to $6,287 for the nine months
2019, principally attributable to the results of the U.K. operations partially
offset by a tax provision for the U.S. operations.



Preferred Stock Dividend:



The terms of the acquisitions in November 2014 resulted in the issuance of
preferred ownership units/stock of UEP Holdings, LLC and UGEL (formerly EPAL) to
the sellers. These preferred units have carried quarterly dividend requirements
on a total value of $55,000,000 at rates ranging from 5.0% to 8.0%. The dividend
rate on the Series B UEP Holdings preferred units which started at 5.5%
increases by 0.5% on the anniversary of the issuance up to a maximum of 8.0%.
The payment of dividends for the nine months ended October 4, 2020 and the three
months ended December 29, 2019 was deferred to preserve cash and provide
additional liquidity. As of October 4, 2020 and December 29, 2019, accrued
dividends of $3,154,042 and $788,599, respectively, were included in accrued
expenses and other liabilities in the accompanying consolidated balance sheets.



Liquidity and Sources of Capital


Cash, as it is needed, is provided by using the Company's lines of credit. These
lines provide for a total borrowing commitment in excess of $43,000,000 subject
to the underlying borrowing base specified in the agreements. Of the total
outstanding borrowings of $18,452,489 at October 4, 2020, $13.9 million of the
lines bears interest at LIBOR or the Eurodollar rate plus a range of 1.95% to
2.45%, depending on the underlying borrowing base and $4.6 million bears
interest at the bank's prime or base lending rate which was 3.25% at October 4,
2020. The lines provided additional availability of approximately $1.7 million
and, combined with UEP's and UGL's total cash balances, liquidity was
approximately $2.4 million at October 4, 2020. We plan to use this availability
and cash provided by operating activities to finance our cash needs for the
remaining months of fiscal 2020 and future periods. The balances due under the
lines of credit are recorded as current liabilities on the consolidated balance
sheets.



As a result of the COVID-19 pandemic, sales of the Company's products are lower
than expected. This has had a negative impact on the Company's working capital
which could affect its ability to borrow using the Company's lines of credit. To
increase its liquidity, as previously discussed, the Company has applied for
loans under programs offered by the governmental agencies in the United States
and in the United Kingdom.



  29


   Table of Contents




For the U.S. operations, early in the second quarter of 2020 the Company
received $2,217,500 in funds through the Paycheck Protection Program
administered by the United States Small Business Administration. The Company
believes that all of this debt will be forgiven; it submitted its application
for loan forgiveness in September 2020. Also for the U.S. operations, during the
third quarter of 2020 the Company applied for a $3.2 million loan from Wells
Fargo Capital Finance, LLC through the Main Street Lending Program established
by the Federal Reserve Board; however, there can be no guarantee that the
Company will be successful in obtaining this funding.



In the U.K., the Company has recorded £1,245,000 ($1,560,000) in funding
available under the Coronavirus Job Retention Scheme which reimbursed the
Company for the compensation expense paid to furloughed employees. Additionally
for the U.K. operations, during the third quarter of 2020 the Company received a
$783,958 loan from its principal shareholder and $1,545,538 in loans from
automotive lenders. Subsequent to October 4, 2020, the Company received
approximately $384,000 in a loan from its majority shareholder and $1.6 million
in loans from automotive lenders with additional availability of approximately
$400,000. These funds provided more working capital to meet various short-term
cash needs.



The Company continues to attempt to manage its operating costs to match the
reduced sales volume. We believe that the increasing sales activities combined
with the funding from nontraditional sources (U.S. and U.K. governments and
automotive lenders) will be sufficient to provide for short-term cash needs.
However, there can be no assurance that additional financing will be available
on favorable terms, if at all.



The ratio of current assets to current liabilities, including the amount due
under our lines of credit, was 0.83 at October 4, 2020 and 0.89 at December

29,
2019.



Cash balances increased $260,281, before the effects of currency translation of
$(5,995), to $767,874 at October 4, 2020 from $513,588 at December 29, 2019. Of
the above noted amounts, $507,370 and $498,007 were held outside the U.S. by our
foreign subsidiaries as of October 4, 2020 and December 29, 2019, respectively.



Cash provided by operations was $966,649 for the nine months 2020 compared to
$2,455,877 for the nine months 2019. For the nine months 2020, cash provided by
operations was primarily due to changes in working capital of $2,772,839 offset
by the net loss of $998,910, changes in other assets and liabilities of
$(428,504) and adjustments for non-cash items of $(378,776). For the nine months
2019, cash provided by operations was primarily due to adjustments for non-cash
items of $1,656,649, net income of $1,273,523 and changes in other assets and
liabilities of $48,683 offset by changes in working capital of $(522,978).



Cash used in investing activities was $1,171,258 for the nine months 2020
compared to $1,457,071 for the nine months 2019. During 2020 and 2019, cash used
in investing activities was principally for purchases of machinery and equipment
at our manufacturing locations and payments made for company-owned key man life
insurance premiums. For the nine months 2020 and 2019, the payments made for the
life insurance premiums were offset by proceeds from policy loans of $130,000
and $249,051, respectively.



For the nine months 2020, cash provided by financing activities was $464,890
compared to cash used in financing activities of $1,186,609 for the nine months
2019. Impacting cash flows from financing activities for the nine months 2020
and 2019 were net payments on lines of credit of $1,913,810 and net advances on
lines of credit of $1,893,069, respectively. The changes in the lines of credit
reflect the funding of working capital. There were no preferred dividend
payments during the nine months 2020 compared to $2,332,503 during the nine
months 2019, which also impacted cash flows from financing activities. As
previously stated, the dividends for the nine months 2020 were deferred to
preserve cash and provide additional liquidity. Also impacting cash flows from
financing activities were proceeds from issuance of long-term debt of $3,737,361
($2,217,500 through the Paycheck Protection Program and $1,545,538, net of
translation adjustment of $25,677, from automotive lenders) for the nine months
2020 and $454,088 for the nine months 2019. Additionally during the nine months
2020 and 2019, our majority shareholder provided $938,958 and $800,000,
respectively, in financing in the form of subordinated secured promissory notes.
Payments of $875,000 and $550,000 were made on these notes during the nine
months 2020 and 2019, respectively.



Our credit agreements contain customary affirmative and negative covenants. We
were in compliance with our debt covenants as of October 4, 2020 and through the
date of filing of this report.



  30


   Table of Contents




We currently have several on-going capital projects that are important to our
long-term strategic goals. Machinery and equipment will also be added as needed
to increase capacity or enhance operating efficiencies in our manufacturing
plants. We will use a combination of financing arrangements to provide the
necessary capital. We believe that our existing resources, including cash on
hand and our credit facilities, together with cash generated from operations and
additional bank borrowings, will be sufficient to fund our cash flow
requirements through at least the next twelve months. However, there can be no
assurance that additional financing will be available on favorable terms, if at
all.


We have no material off balance sheet arrangements.





  31


   Table of Contents

© Edgar Online, source Glimpses